Product Information

CLINDAMYCIN HCL 75 MG CAPSULE is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2508 per EA under NDC 68462014201. Its NADAC has been published 147 times since Jun 7, 2023.

FDA first approved this application on Mar 10, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLINDAMYCIN HCL 75 MG CAPSULE

Clindamycin Hydrochloride
$0.2508per EA

Strength

75 mg/1

NDC

68462014201

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CLINDAMYCIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA216957

FDA Approved

3/10/2023

TE Code

AB

On Market Since

3/10/2023

Pharmacological Classes

Decreased Sebaceous Gland Activity
Lincosamide Antibacterial
Lincosamides
Neuromuscular Blockade

Price Statistics

The NADAC for CLINDAMYCIN HCL 75 MG CAPSULE has been published 147 times since Jun 7, 2023, and over the history we have for it it has declined 23.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2508 per EA
All-time high$0.3314 (Aug 13, 2025)
All-time low$0.2389 (Aug 21, 2024)
52-week high$0.3293
52-week low$0.2508
Median price$0.2948
Average price$0.2926
Largest weekly change-11.9% (May 22, 2024)
Weeks tracked147
Tracking sinceJun 7, 2023

Price History

1W

-3.2%

1M

-3.2%

3M

-13.7%

6M

-16.9%

1Y

-23.8%

3Y

-23.8%

5Y

N/A

All

-23.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of CLINDAMYCIN HCL 75 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN HCL 75 MG CAPSULE, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2508 per EA (NDC 68462014201), effective Aug 19, 2026.

How has the price of CLINDAMYCIN HCL 75 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for CLINDAMYCIN HCL 75 MG CAPSULE has declined 23.8%. It has been tracked across 147 weekly CMS publications since Jun 7, 2023.

What are the highest and lowest recorded NADAC prices for CLINDAMYCIN HCL 75 MG CAPSULE?

Since Jun 7, 2023, the NADAC for CLINDAMYCIN HCL 75 MG CAPSULE has ranged from a low of $0.2389 (Aug 21, 2024) to a high of $0.3314 (Aug 13, 2025), with a median of $0.2948 per EA.

Are there cheaper alternatives to CLINDAMYCIN HCL 75 MG CAPSULE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CLINDAMYCIN HCL 75 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures CLINDAMYCIN HCL 75 MG CAPSULE?

CLINDAMYCIN HCL 75 MG CAPSULE (NDC 68462014201) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.